As previously reported, the strongest PSMA expression, as determined by immunohistochemistry, was seen in ccRCC, whereas pRCC showed a lower PSMA expression, in line with our PET findings for nodal and osseous metastases [8]. Here, FOLH1 is linked to nonpapillary renal cell carcinoma.